Speciality: Emergency Medicine
Description:
A warm welcome to all the medical professionals in this interesting session on the potential benefits of intravenous glutamine therapy.
Intravenous (IV) glutamine therapy has garnered attention for its potential therapeutic benefits in various clinical settings. Glutamine, an amino acid, plays a crucial role in numerous physiological processes, including protein synthesis, immune function, and cellular metabolism.
IV administration of glutamine bypasses the digestive system, allowing for rapid absorption and delivery of this essential nutrient directly into the bloodstream. This method is particularly beneficial for patients with conditions such as critical illness, sepsis, and intestinal failure, where oral intake may be compromised or insufficient. IV glutamine supplementation aims to replenish depleted glutamine stores, support immune function, and promote tissue repair and recovery in critically ill patients.
The use of IV glutamine therapy extends beyond critical care settings, with emerging evidence suggesting potential benefits in other clinical scenarios. For example, IV glutamine has shown promise in reducing chemotherapy-induced mucositis and improving outcomes in patients undergoing bone marrow transplantation.
Therefore, get an overall knowledge on the understanding of the potential benefits of intravenous glutamine therapy. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
See More Webinars @ Hidoc Webinars
1.
A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.
2.
The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.
5.
A garden can save your life
1.
Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy
2.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
3.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
4.
Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care
5.
Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation